Alkermes plc
US ˙ NasdaqGS ˙ IE00B56GVS15

Introduction

This page provides a comprehensive analysis of the known insider trading history of Frank Anders Wilson. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Frank Anders Wilson has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ALKS / Alkermes plc Director 31,084
US:CBT / Cabot Corporation Director 16,254
US:NOVT / Novanta Inc. Director 2,622
US:SPA / Sparton Corp. Director 0
US:PKI / Revvity Inc. Please See Remarks 17,654
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Frank Anders Wilson. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ALKS / Alkermes plc - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ALKS / Alkermes plc. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ALKS / Alkermes plc Insider Trades
Insider Sales ALKS / Alkermes plc - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ALKS / Alkermes plc. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ALKS / Alkermes plc Insider Trades
Insider Purchases CBT / Cabot Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ALKS / Alkermes plc. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CBT / Cabot Corporation Insider Trades
Insider Sales CBT / Cabot Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ALKS / Alkermes plc. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CBT / Cabot Corporation Insider Trades
Insider Purchases GSIG / Goldman Sachs ETF Trust - Goldman Sachs Access Investment Grade Corporate 1-5 Year Bond ETF - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ALKS / Alkermes plc. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GSIG / Goldman Sachs ETF Trust - Goldman Sachs Access Investment Grade Corporate 1-5 Year Bond ETF Insider Trades
Insider Sales GSIG / Goldman Sachs ETF Trust - Goldman Sachs Access Investment Grade Corporate 1-5 Year Bond ETF - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ALKS / Alkermes plc. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GSIG / Goldman Sachs ETF Trust - Goldman Sachs Access Investment Grade Corporate 1-5 Year Bond ETF Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Frank Anders Wilson as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-06-02 2025-05-31 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -1,924 31,084 -5.83 30.61 -58,894 951,481
2025-06-02 2025-05-31 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8,013 33,008 32.06
2025-01-14 2025-01-10 4 CBT CABOT CORP
Common Stock
A - Award 1,788 16,254 12.36
2025-01-06 2025-01-02 4 NOVT NOVANTA INC
Common Stock
M - Exercise 1,217 2,622 86.62
2024-07-08 2024-07-03 4 NOVT NOVANTA INC
Common Stock
M - Exercise 278 1,405 24.67
2024-07-01 2024-06-29 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -1,465 24,995 -5.54 24.10 -35,306 602,380
2024-07-01 2024-06-29 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 6,104 26,460 29.99
2024-01-12 2024-01-11 4 CBT CABOT CORP
Common Stock
A - Award 2,035 14,466 16.37
2024-01-04 2024-01-03 4 NOVT NOVANTA INC
Common Stock
M - Exercise 464 1,127 69.98
2023-07-10 2023-07-07 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -1,430 20,356 -6.56 29.88 -42,728 608,237
2023-07-10 2023-07-07 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 5,957 21,786 37.63
2023-01-13 2023-01-12 4 CBT CABOT CORP
Common Stock
A - Award 1,854 12,431 17.53
2023-01-05 2023-01-03 4 NOVT NOVANTA INC
Common Stock
M - Exercise 359 663 118.09
2022-06-16 2022-06-14 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -695 15,829 -4.21 27.19 -18,897 430,391
2022-06-16 2022-06-14 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 7,585 16,524 84.85
2022-05-16 2022-05-13 4 NOVT NOVANTA INC
Restricted Stock Units
M - Exercise -304 0 -100.00
2022-05-16 2022-05-13 4 NOVT NOVANTA INC
Common Stock
M - Exercise 304 304
2022-04-07 2022-04-05 4 NOVT NOVANTA INC
Deferred Stock Units
A - Award 40 703 6.03
2022-01-14 2022-01-13 4 CBT CABOT CORP
Common Stock
A - Award 2,254 10,577 27.08
2022-01-05 2022-01-03 4 NOVT NOVANTA INC
Deferred Stock Units
A - Award 359 663 118.09
2022-01-05 2022-01-03 4 NOVT NOVANTA INC
Restricted Stock Units
A - Award 359 359
2021-12-03 2021-12-02 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -5,578 0 -100.00
2021-12-03 2021-12-02 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -1,339 8,939 -13.03 22.11 -29,605 197,641
2021-12-03 2021-12-02 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 5,578 10,278 118.68
2021-06-16 2021-06-14 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 7,585 7,585
2021-06-16 2021-06-14 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
A - Award 15,677 15,677
2021-05-21 2021-05-20 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -6,104 0 -100.00
2021-05-21 2021-05-20 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -1,404 4,700 -23.00 21.92 -30,776 103,024
2021-05-21 2021-05-20 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 6,104 6,104
2021-05-14 2021-05-13 4 NOVT NOVANTA INC
Deferred Stock Units
A - Award 304 304
2021-05-14 2021-05-13 4 NOVT NOVANTA INC
Restricted Stock Units
A - Award 304 304
2021-01-11 2021-01-07 4 CBT CABOT CORP
Common Stock
A - Award 2,489 8,323 42.66
2020-12-04 2020-12-02 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 5,578 5,578
2020-12-04 2020-12-02 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
A - Award 11,509 11,509
2020-05-22 2020-05-20 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 6,104 6,104
2020-05-22 2020-05-20 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
A - Award 12,823 12,823
2020-01-13 2020-01-09 4 CBT CABOT CORP
Common Stock
A - Award 2,635 5,834 82.37
2019-12-09 2019-12-04 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
A - Award 61,800 61,800
2019-12-09 2019-12-04 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
A - Award 11,200 11,200
2019-03-04 2019-03-04 4 SPA SPARTON CORP
Common Stock
D - Sale to Issuer -7,972 0 -100.00 18.50 -147,482
2019-01-14 2019-01-10 4 CBT CABOT CORP
Common Stock
A - Award 2,613 3,199 445.90
2018-09-17 2018-09-13 4 CBT CABOT CORP
Common Stock
A - Award 586 586
2018-09-17 3 CBT CABOT CORP
No securities are beneficially owned
0
2018-03-06 2018-03-05 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -8,827 17,654 -33.33
2018-03-06 2018-03-05 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -28,016 14,008 -66.67
2018-03-06 2018-03-05 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -35,114 0 -100.00
2018-03-06 2018-03-05 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -31,699 0 -100.00
2018-03-06 2018-03-05 4 PKI PERKINELMER INC
Common Stock
S - Sale X -48,029 61,925 -43.68 74.28 -3,567,594 4,599,789
2018-03-06 2018-03-05 4 PKI PERKINELMER INC
Common Stock
S - Sale X -55,627 109,654 -33.66 73.64 -4,096,372 8,074,921
2018-03-06 2018-03-05 4 PKI PERKINELMER INC
Common Stock
M - Exercise 8,827 165,581 5.63 52.65 464,742 8,717,840
2018-03-06 2018-03-05 4 PKI PERKINELMER INC
Common Stock
M - Exercise 28,016 156,754 21.76 41.80 1,171,069 6,552,317
2018-03-06 2018-03-05 4 PKI PERKINELMER INC
Common Stock
M - Exercise 35,114 128,738 37.51 46.26 1,624,198 5,954,776
2018-03-06 2018-03-05 4 PKI PERKINELMER INC
Common Stock
M - Exercise 31,699 93,624 51.19 43.01 1,363,374 4,026,768
2018-02-07 2018-02-05 4 PKI PERKINELMER INC
Common Stock
F - Taxes -3,217 61,925 -4.94 78.08 -251,183 4,835,104
2017-12-08 2017-12-07 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -29,052 0 -100.00
2017-12-08 2017-12-07 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -41,439 0 -100.00
2017-12-08 2017-12-07 4 PKI PERKINELMER INC
Common Stock
S - Sale X -37,535 65,142 -36.56 70.14 -2,632,705 4,569,060
2017-12-08 2017-12-07 4 PKI PERKINELMER INC
Common Stock
M - Exercise 29,052 135,633 27.26 33.87 983,991 4,593,890
2017-12-08 2017-12-07 4 PKI PERKINELMER INC
Common Stock
M - Exercise 41,439 106,581 63.61 26.14 1,083,423 2,786,560
2017-03-15 2017-03-13 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -37,535 0 -100.00
2017-03-15 2017-03-13 4 PKI PERKINELMER INC
Common Stock
S - Sale X -37,535 65,141 -36.56 55.45 -2,081,391 3,612,199
2017-03-15 2017-03-13 4 PKI PERKINELMER INC
Common Stock
M - Exercise 37,535 102,676 57.62 26.58 997,680 2,729,128
2017-02-08 2017-02-07 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
A - Award 26,481 26,481
2017-02-08 2017-02-07 4 PKI PERKINELMER INC
Common Stock
A - Award 5,797 65,141 9.77
2017-02-08 2017-02-06 4 PKI PERKINELMER INC
Common Stock
F - Taxes -2,841 59,344 -4.57 52.17 -148,215 3,095,976
2016-11-14 2016-11-10 4 SPA SPARTON CORP
Common Stock
A - Award 2,254 7,972 39.42
2016-09-22 2016-09-22 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -46,611 0 -100.00
2016-09-22 2016-09-22 4 PKI PERKINELMER INC
Common Stock
S - Sale X -46,611 62,185 -42.84 55.00 -2,563,605 3,420,175
2016-09-22 2016-09-22 4 PKI PERKINELMER INC
Common Stock
M - Exercise 46,611 108,795 74.96 21.01 979,297 2,285,783
2016-02-10 2016-02-09 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
A - Award 42,024 42,024
2016-02-10 2016-02-09 4 PKI PERKINELMER INC
Common Stock
A - Award 9,342 62,184 17.68
2016-02-10 2016-02-08 4/A SPA SPARTON CORP
Common Stock
P - Purchase 1,500 5,718 35.56 12.15 18,223 69,466
2016-02-08 2016-02-08 4 SPA SPARTON CORP
common stock
P - Purchase 1,500 5,718 35.56 12.15 18,223 69,466
2016-02-08 2016-02-05 4 PKI PERKINELMER INC
Common Stock
F - Taxes -3,017 52,842 -5.40 46.58 -140,532 2,461,380
2015-11-12 2015-11-09 4 SPA SPARTON CORP
Common Stock
A - Award 2,190 4,218 107.99
2015-11-04 2015-11-03 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -16,380 0 -100.00
2015-11-04 2015-11-03 4 PKI PERKINELMER INC
Common Stock
S - Sale X -16,380 55,859 -22.67 52.69 -863,013 2,943,043
2015-11-04 2015-11-03 4 PKI PERKINELMER INC
Common Stock
M - Exercise 16,380 72,239 29.32 16.20 265,438 1,170,633
2015-06-04 2015-06-03 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -16,380 16,380 -50.00
2015-06-04 2015-06-03 4 PKI PERKINELMER INC
Common Stock
S - Sale X -16,380 55,858 -22.68 52.60 -861,539 2,937,963
2015-06-04 2015-06-03 4 PKI PERKINELMER INC
Common Stock
M - Exercise 16,380 72,238 29.32 16.20 265,438 1,170,617
2015-05-20 2015-02-20 4 SPA SPARTON CORP
Common Stock
A - Award 2,028 2,028
2015-02-10 2015-02-09 4 PKI PERKINELMER INC
Common Stock
F - Taxes -3,766 55,858 -6.32 45.98 -173,161 2,568,351
2015-02-04 2015-02-03 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
A - Award 35,114 35,114
2015-02-04 2015-02-03 4 PKI PERKINELMER INC
Common Stock
A - Award 8,248 59,624 16.05
2014-02-11 2014-02-10 4 PKI PERKINELMER INC
Common Stock
F - Taxes -3,575 51,375 -6.51 43.78 -156,514 2,249,198
2014-02-06 2014-02-04 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
A - Award 31,699 31,699
2014-02-06 2014-02-04 4 PKI PERKINELMER INC
Common Stock
A - Award 8,754 54,949 18.95
2013-02-12 2013-02-11 4 PKI PERKINELMER INC
Common Stock
F - Taxes -4,328 46,194 -8.57 34.75 -150,398 1,605,242
2013-02-07 2013-02-05 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
A - Award 29,052 29,052
2013-02-07 2013-02-05 4 PKI PERKINELMER INC
Common Stock
A - Award 9,297 50,522 22.55
2012-11-27 2012-11-26 4 PKI PERKINELMER INC
Common Stock
P - Purchase 82 41,225 0.20 31.19 2,558 1,285,808
2012-02-09 2012-02-07 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
A - Award 41,439 41,439
2012-02-09 2012-02-07 4 PKI PERKINELMER INC
Common Stock
A - Award 11,586 41,143 39.20
2012-02-09 2011-12-30 4 PKI PERKINELMER INC
Common Stock
P - Purchase 118 29,557 0.40 20.02 2,362 591,731
2012-01-31 2012-01-27 4 PKI PERKINELMER INC
Common Stock
F - Taxes -979 29,439 -3.22 24.12 -23,613 710,069
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)